» Articles » PMID: 3257146

Increases in Neutrophil Counts by Purified Human Urinary Colony-stimulating Factor in Chronic Neutropenia of Childhood

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1988 Jan 1
PMID 3257146
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical effects of purified human urinary colony-stimulating factor (CSFHU) were studied in nine patients with chronic neutropenia of childhood who ranged in age from 1 to 18 years. The patients were given CSFHU at a dose of 6 x 10(6) U/m2/d for seven consecutive days, and their peripheral neutrophil counts were serially followed for 6 to 12 months. In addition, changes in bone marrow morphology and granulocyte-macrophage colony-forming cells (GM-CFUs) were studied. Transient increases in neutrophil counts occurred during the first 4 weeks in all patients except one. Repeated increases were seen in a cyclic fashion in five patients. Three of the patients recovered from the neutropenia after several cycles of fluctuation of neutrophil counts; the counts (per microliter) reached 5,880, 5,640, and 2,000 as compared with pretreatment levels (mean +/- 2 SD) of 80 +/- 164, 182 +/- 250, and 2 +/- 14, respectively. The percentage (mean +/- SE) of marrow neutrophilic cells increased from 30.4% +/- 7.0% to 34.9% +/- 6.9% (P less than .05) and the ratio of the later neutrophil precursors to the earlier ones from 1.02 +/- 0.27 to 1.42 +/- 0.36 (P less than .02) 2 weeks after CSFHU infusion. There were no changes in GM-CFU numbers. These results indicate that CSFHU can increase neutrophil counts by increasing the number and maturity of the marrow neutrophil precursors in some types of childhood chronic neutropenia.

Citing Articles

Neutrophil disorders and their management.

Lakshman R, Finn A J Clin Pathol. 2001; 54(1):7-19.

PMID: 11271792 PMC: 1731272. DOI: 10.1136/jcp.54.1.7.


Clinical toxicity of cytokines used as haemopoietic growth factors.

Vial T, Descotes J Drug Saf. 1995; 13(6):371-406.

PMID: 8652081 DOI: 10.2165/00002018-199513060-00006.


Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.

Ishiguro A, Nakahata T, Shimbo T, Amano Y, Yasui K, Koike K Eur J Pediatr. 1993; 152(1):18-20.

PMID: 7680314 DOI: 10.1007/BF02072510.


Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Broxmeyer H, Vadhan-Raj S Immunol Res. 1989; 8(3):185-201.

PMID: 2664033 DOI: 10.1007/BF02918144.